Search results

  • Dr. Gordana Milavić

    ACAMH 2021 AGM

    Details of how to join the 2021, on Thursday 4 November, 1.30pm UK time. Plus minutes of the 2020 AGM, Member’s Report 2021, and Agenda for the 2021 AGM.

    Read more
  • rd-bridge-tools-helping-school-against-self-harm

    How effective are tools to help school staff better respond to young people who self-harm?

    Aureliane Pierret and colleagues at the University of Cambridge carried out a systematic review into the effectiveness, feasibility and acceptability of interventions and tools to support school staff to better respond to young people who disclose self-harm.

    Read more
  • Bridge front cover

    2021 New Issue 1

    The Bridge Relaunch edition, October 2021, with an introduction by editor Dr Stephanie Lewis.

    Read more
  • Autism and Eating Disorders – CAMHS Campfire recording

    For this session we welcomed Dr. Francesca Solmi (pic), UCL, and Dr. Lisa Dinkler, Karolinska Institutet to discuss papers on Autism and Eating Disorders. ACAMH members can now receive a CPD certificate for watching this recorded lecture.

    Read more
  • Neurodevelopmental series

    ‘NDC Learning Series’ – Medications and Physical Health

    Bookings are closed. This is the fifth of the ‘NDC Learning Series’ aimed at health professionals who come into contact with children and young people who have Neurodevelopmental conditions (NDCs). We are delighted to welcome Dr. Mark Lovell and Dr. Max Davie. with a session that will focus on ‘Medications and Physical Health’. The Chair of this session is Dr. Ann Ozsivadjian. 

    Event type
    Special Interest Group (SIG)
    Location
    LIVE STREAM
    Read more
  • Neurodevelopmental series

    ‘NDC Learning Series’ – NDCs in schools

    This is the fourth of the ‘NDC Learning Series’ aimed at health professionals who come into contact with children and young people who have Neurodevelopmental conditions (NDCs). We are delighted to welcome Dr. James Galpin with a session that will focus on ‘NDCs in schools’. The Chair of this session is Dr. Mark Lovell. 

    Event type
    Special Interest Group (SIG)
    Location
    LIVE STREAM
    Read more
  • Neurodevelopmental series

    ‘NDC Learning Series’ – Behaviour that challenges

    Booking are closed. This is the third of the ‘NDC Learning Series’ aimed at health professionals who come into contact with children and young people who have Neurodevelopmental conditions (NDCs). We are delighted to welcome Dr. Mark Lovell and Dr. Steph Carr, with a session that will focus on ‘Behaviour that challenges’. The Chair for this session is Dr. Max Davie.

    Location
    LIVE STREAM
    Read more
  • Neurodevelopmental series

    ‘NDC Learning Series’ – Communication and functional skills

    This is the final of the ‘NDC Learning Series’ aimed at health professionals who come into contact with children and young people who have Neurodevelopmental conditions (NDCs). We are delighted to welcome Dr. Lucy Sanctuary, and Occupational Therapist Dr. Sally Payne, to discuss ‘Communication and functional skills’. The Chair of this session is Dr. Mark Lovell.

    Event type
    Special Interest Group (SIG)
    Location
    LIVE STREAM
    Read more
  • Neurodevelopmental series

    ‘NDC Learning Series’ – Working Together

    This is the first of the ‘NDC Learning Series’ aimed at health professionals who come into contact with children and young people who have Neurodevelopmental conditions (NDCs). We are delighted to welcome Sue North MBE and Georgia Harper, with a session that will focus on ‘Working Together’. The Chair for this session is Dr. Max Davie.

    Event type
    SIG
    Location
    LIVE STREAM
    Read more
  • Professor Tim Dalgleish

    PTSD in very young children, and proof-of-concept trial – In Conversation Prof. Tim Dalgleish

    The focus of this podcast is on the JCPP paper ‘The early course and treatment of posttraumatic stress disorder in very young children: diagnostic prevalence and predictors in hospital-attending children and a randomized controlled proof-of-concept trial of trauma-focused cognitive therapy, for 3- to 8-year-olds’

    Read more